Treatment of fungal pyelonephritis and ureterolithiasis with a subcutaneous ureteral bypass system and systemic antifungal medication in a cat
Rebecca G McQuitty,1 Erinne M Branter2 1Emergency and Critical Care Department, ACCESS Specialty Animal Hospital, Culver City, CA, USA; 2Interventional Radiology/Endoscopy Department, ACCESS Specialty Animal Hospital, Culver City, CA, USA Purpose: We describe a case of ureteral obstruction and funga...
Guardado en:
Autores principales: | , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/63238d92e44c44b6bccbe056d7aecf53 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:63238d92e44c44b6bccbe056d7aecf53 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:63238d92e44c44b6bccbe056d7aecf532021-12-02T06:00:43ZTreatment of fungal pyelonephritis and ureterolithiasis with a subcutaneous ureteral bypass system and systemic antifungal medication in a cat2230-2034https://doaj.org/article/63238d92e44c44b6bccbe056d7aecf532018-11-01T00:00:00Zhttps://www.dovepress.com/treatment-of-fungal-pyelonephritis-and-ureterolithiasis-with-a-subcuta-peer-reviewed-article-VMRRhttps://doaj.org/toc/2230-2034Rebecca G McQuitty,1 Erinne M Branter2 1Emergency and Critical Care Department, ACCESS Specialty Animal Hospital, Culver City, CA, USA; 2Interventional Radiology/Endoscopy Department, ACCESS Specialty Animal Hospital, Culver City, CA, USA Purpose: We describe a case of ureteral obstruction and fungal pyelonephritis in a cat. The case was managed successfully with a subcutaneous ureteral bypass (SUB) device and systemic antifungal medication. Case summary: A 9-year-old, male, neutered, domestic shorthair cat was referred for severe azotemia, ureteral obstruction, and sonographically identified progressive pyelectasia of the left kidney. A SUB device was placed. Cytology of the left kidney subsequently identified fungal organisms, and the cat responded clinically to treatment with fluconazole and supportive care. The cat survived for 11 months with intermittent fluconazole treatment. Conclusion: Fungal pyelonephritis should be considered as a possible concurrent diagnosis in cats with ureteral obstruction. The successful clinical outcome in this case suggests that treatment with SUB placement, antifungal medication, and supportive care could be an effective treatment strategy. Keywords: interventional radiology, ureteral obstruction, mycoses, invasive fungal disease, urinary tract infectionMcQuitty RGBranter EMDove Medical Pressarticleinterventional radiologyureteral obstructionmycosesinvasive fungal diseaseurinary tract infectionVeterinary medicineSF600-1100ENVeterinary Medicine: Research and Reports, Vol Volume 9, Pp 73-78 (2018) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
interventional radiology ureteral obstruction mycoses invasive fungal disease urinary tract infection Veterinary medicine SF600-1100 |
spellingShingle |
interventional radiology ureteral obstruction mycoses invasive fungal disease urinary tract infection Veterinary medicine SF600-1100 McQuitty RG Branter EM Treatment of fungal pyelonephritis and ureterolithiasis with a subcutaneous ureteral bypass system and systemic antifungal medication in a cat |
description |
Rebecca G McQuitty,1 Erinne M Branter2 1Emergency and Critical Care Department, ACCESS Specialty Animal Hospital, Culver City, CA, USA; 2Interventional Radiology/Endoscopy Department, ACCESS Specialty Animal Hospital, Culver City, CA, USA Purpose: We describe a case of ureteral obstruction and fungal pyelonephritis in a cat. The case was managed successfully with a subcutaneous ureteral bypass (SUB) device and systemic antifungal medication. Case summary: A 9-year-old, male, neutered, domestic shorthair cat was referred for severe azotemia, ureteral obstruction, and sonographically identified progressive pyelectasia of the left kidney. A SUB device was placed. Cytology of the left kidney subsequently identified fungal organisms, and the cat responded clinically to treatment with fluconazole and supportive care. The cat survived for 11 months with intermittent fluconazole treatment. Conclusion: Fungal pyelonephritis should be considered as a possible concurrent diagnosis in cats with ureteral obstruction. The successful clinical outcome in this case suggests that treatment with SUB placement, antifungal medication, and supportive care could be an effective treatment strategy. Keywords: interventional radiology, ureteral obstruction, mycoses, invasive fungal disease, urinary tract infection |
format |
article |
author |
McQuitty RG Branter EM |
author_facet |
McQuitty RG Branter EM |
author_sort |
McQuitty RG |
title |
Treatment of fungal pyelonephritis and ureterolithiasis with a subcutaneous ureteral bypass system and systemic antifungal medication in a cat |
title_short |
Treatment of fungal pyelonephritis and ureterolithiasis with a subcutaneous ureteral bypass system and systemic antifungal medication in a cat |
title_full |
Treatment of fungal pyelonephritis and ureterolithiasis with a subcutaneous ureteral bypass system and systemic antifungal medication in a cat |
title_fullStr |
Treatment of fungal pyelonephritis and ureterolithiasis with a subcutaneous ureteral bypass system and systemic antifungal medication in a cat |
title_full_unstemmed |
Treatment of fungal pyelonephritis and ureterolithiasis with a subcutaneous ureteral bypass system and systemic antifungal medication in a cat |
title_sort |
treatment of fungal pyelonephritis and ureterolithiasis with a subcutaneous ureteral bypass system and systemic antifungal medication in a cat |
publisher |
Dove Medical Press |
publishDate |
2018 |
url |
https://doaj.org/article/63238d92e44c44b6bccbe056d7aecf53 |
work_keys_str_mv |
AT mcquittyrg treatmentoffungalpyelonephritisandureterolithiasiswithasubcutaneousureteralbypasssystemandsystemicantifungalmedicationinacat AT branterem treatmentoffungalpyelonephritisandureterolithiasiswithasubcutaneousureteralbypasssystemandsystemicantifungalmedicationinacat |
_version_ |
1718400113494196224 |